SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Biocept, Inc.
(NASDAQ: BIOC), a leading commercial provider of liquid biopsy
tests designed to provide physicians with clinically actionable
information to improve the outcomes of patients diagnosed with
cancer, announces that it will release financial results for the
three and six months ended June 30,
2019 after the market closes on Monday, August 12, 2019. The Company will host a
conference call for the investment community to discuss the results
and answer questions at 4:30 p.m. Eastern
time (1:30 p.m. Pacific
time).
Individuals interested in participating on the conference call
may do so by dialing (855) 656-0927 for domestic callers, (855)
669-9657 for Canadian callers, or (412) 902-4109 for other
international callers. Those interested in listening to a webcast
of the live conference call may do so by
visiting https://www.webcaster4.com/Webcast/Page/1271/31194.
A replay of the conference call will be available for 48 hours
following the conclusion of the call by dialing (877) 344-7529 for
domestic callers, (855) 669-9658 for Canadian callers, or (412)
317-0088 for other international callers, and entering the replay
access code 10133829. A webcast replay will be available for 90
days at http://ir.biocept.com/events.cfm.
About Biocept
Biocept, Inc. is a molecular
diagnostics company with commercialized assays for lung, breast,
gastric, colorectal and prostate cancers, and melanoma. The Company
uses its proprietary liquid biopsy technology to provide physicians
with information for treating and monitoring patients diagnosed
with cancer. The Company's patented Target Selector™ liquid biopsy
technology platform captures and analyzes tumor-associated
molecular markers in both circulating tumor cells (CTCs) and in
plasma (ctDNA). With thousands of tests performed, the platform has
demonstrated the ability to identify cancer mutations and
alterations to inform physicians about a patient's disease and
therapeutic options. For additional information, please
visit www.biocept.com.
Investor Contact:
LHA Investor
Relations
Jody Cain
Jcain@lhai.com
310-691-7100
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biocept-to-release-second-quarter-2019-financial-results-and-host-investor-conference-call-on-august-12-2019-300895443.html
SOURCE Biocept, Inc.